JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
IBRX - Immunitybio, Inc.
USD | NASDAQ | Healthcare
Summary
Summary IBRX Stock
Financials
Financials IBRX Stock
Loading...
Loading...
Income Statement
Income Statement IBRX Stock
Balance Sheet
Balance Sheet IBRX Stock
Cash Flow Statement
Cash Flow Statement IBRX Stock
Loading...
Loading...
IBRX Financials - Immunitybio Income & Cash Flow | Ledgeburg
Home
Stocks
Immunitybio, Inc. (IBRX)
Financials
Financials of IBRX
Loading...
Loading...
Loading...
Loading...
Revenue
$113.288M
Operating Income
$-256.027M
Net Income
$-351.472M
Share Count (Basic)
919.863M
Operating Cash Flow
$-304.936M
Free Cash Flow
$-308.782M
Cash And Short-Term Equivalents
$242.818M
Total Debt
$1.751M
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
80M
100M
120M
FY2021
FY2022
Revenue $USD
0
10M
20M
30M
40M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-600M
-550M
-500M
-450M
-400M
-350M
Annual
Quarterly
Margins
Gross
Operating
Net
-150000%
-100000%
-50000%
0%
FY2023
FY2024
FY2025
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-600M
-400M
-200M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-1500%
-1000%
-500%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26